Skip to content

A Computerized Intervention for Depression

A Computerized Intervention for Depression

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02655588
Enrollment
45
Registered
2016-01-14
Start date
2014-09-30
Completion date
2016-10-20
Last updated
2017-03-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression

Brief summary

The primary purpose of this study is to examine how much change in depressive symptoms will be observed in persons who use an electronic Problem Solving Treatment (imbPST) compared to a control group at pre-, mid-point, and post-test assessments.

Detailed description

An interactive multimedia computer-based treatment program was developed to provide an electronic version of problem solving therapy for depression (imbPST). The program was entirely automated and did not require the involvement of a live clinician, even though it was designed to provide a virtual therapy experience that feels more like interacting with a person than with a computer. The imbPST program was built to help individuals who did not have access to traditional therapy due the living conditions or individual preferences (e.g. rural, poor and persons desiring privacy or with significant time constraints). This computer-based treatment of depression offered several advantages. It can be used anywhere without a therapist present, and offered a standardized and consistent therapeutic approach. The aim of this study is to reduce symptoms of depression in subjects through the use of a new, electronic Problem Solving Treatment (imbPST). Adult participants with moderate to severe depression symptoms are randomly assigned to either treatment or a wait-list condition. The Beck Depression Inventory-II was used as the primary outcome measure

Interventions

BEHAVIORALInteractive Media-Based Problems Solving Treatment

Sponsors

Harvard University
CollaboratorOTHER
William Stone
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. Be 18 years of age or older. 2. Present symptoms from the following criteria based on the Diagnostic & Statistical Manual of Mental Disorders-IV-Text Revision (DSM-IV-TR): Major Depressive Episode, Mood Disorder Due to a General Medical Condition and/or Adjustment Disorder with Depressed Mood. 3. Depression must be the primary diagnosis and not occur secondary to any another diagnosis such as Post-Traumatic Stress Disorder (PTSD), social phobia, or complicated bereavement, though comorbid diagnoses (e.g., anxiety disorders and PTSD) will not be exclusionary unless they are primary, except as specified below. 4. Not receiving psychological treatment (e.g., face to face) at the time of the study. 5. Not currently be receiving Problem Solving Treatment in any other context. 6. Not reporting/reported suicidal attempts in the year prior to their participation in the study. 7. Be able to write and speak English according to Rapid Estimate of Adult Literacy in Medicine (REALM test scores)

Exclusion criteria

1. Current suicidal ideation, history of suicidal attempts or self-injurious behavior at any point during the protocol. 2. Have been diagnosed with schizophrenia, bipolar I disorder, with psychosis, other disorder with psychotic symptoms, and/or brain injuries that includes loss of consciousness \> 15 minutes and / post-traumatic amnesia of any duration. 3. Any history of treatment with anti-psychotic medication. 4. A felony conviction. 5. Any current or recent (i.e. within the previous 6 months) substance abuse/dependence diagnosis (other than nicotine or caffeine). 6. Current psychological treatment (e.g., face to face).

Design outcomes

Primary

MeasureTime frameDescription
Symptoms of Depression will be assessed by using the Beck Depression Inventory IIWithin the first 9 weeks after initiating treatment.Self-report measure for symptoms of depression

Secondary

MeasureTime frameDescription
Software usability will be measured by the System Usability Scaleat baseline (week 0),and post-treatment ( week 9)Self-report measure
Symptoms of Depression will be assessed by using the Hopkins Symptom Checklist 20-item Depression Scale ( Self-report)Within the first 9 weeks after initiating treatment.Self-report measure for symptoms of depression

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026